NOVOS
PrivateLast Round
Strategic
Mar 5, 2026
Total Funding Raised
$3.15M
Company Overview
NOVOS is a longevity biotechnology company that develops science-backed nutraceuticals and personalized tools to support healthy aging and extend human healthspan.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NOVOS Comparables
Compare NOVOS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elysium Health | 91% | |
| DoNotAge | 88% | |
| Blueprint | 87% |
NOVOS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 5, 2026 | ||||
| Pre Seed | Oct 1, 2021 |
NOVOS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Awesome People Ventures | Pre Seed |
| Uncommon Denominator | Pre Seed |
| Longevitytech.fund | Pre Seed |
| Resolute Ventures | Pre Seed |
| Arkitekt Ventures | Pre Seed |
| Arkitekt Ventures | Pre Seed |
| Unilever Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2025
Added The Big Fat Fix, a media startup, as a customer.
NOVOS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NOVOS's valuation, stock price, and market status.
Is NOVOS a public or private company?
NOVOS is a private company.
What is the current stock price of NOVOS?
NOVOS is a private company, so its shares have no public market price. Caplight tracks NOVOS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NOVOS worth (valuation)?
Valuation information for NOVOS is not publicly available.
Can I buy NOVOS stock?
NOVOS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NOVOS's last funding round?
NOVOS's most recent funding round was Strategic on March 5, 2026.
Who are the main investors in NOVOS?
Key investors in NOVOS include Resolute Ventures, Unilever Ventures.
Will NOVOS IPO soon?
No public IPO plans have been announced for NOVOS.
How can I track NOVOS secondary market activity?
Caplight tracks bids, offers, and trades in NOVOS's shares on secondary markets.